Clinical Trial Update: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy [NA]

View source ↗

Summary

The trial studied residual hypermethylation in early-stage non-small cell lung cancer as part of adjuvant therapy and a preventive strategy. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Miami | Conditions: Lung Cancer, Non Small Cell Lung Carcinoma | NA | Status: COMPLETED | Results posted: 2015-02-24